BUDECORT

Dosage : Inhaler
Contains : Budesonide
Category : β2-adrenergic receptor agonist
Uses : bronchospasm, asthma, chronic obstructive pulmonary disease
Price :

The oral inhalation formulation is used for the treatment of asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis.

 

Budesonide is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Additionally, it is used for Crohn’s disease (inflammatory bowel disease).

 

Your doctor may have prescribed Budecort because you could be suffering from Inflammation in conditions like Asthma and Inflammatory Bowel Syndrome.

 

Budecort is an inhaler that contains the active substance Budesonide. It is an anti-inflammatory drug that works by decreasing the body’s natural defense response which reduces the irritation and swelling of the airways and also the intestine.

 

Wheezing and shortness of breath can occur due to tightness or pressure in the chest which may result when the lungs can’t hold as much air when they are affected by swelling or mucus buildup. It can be caused by asthma or chronic obstructive pulmonary disease (COPD),and also Due to inflammation in the intestines.

 

Patients suffering from wheezing, shortness of breath and inflammation in the bowel should prevent symptoms such as weakness, weight loss, nausea, muscle pain, headache, tiredness and dizziness. Budecort can be used to treat disorders that may include:

 

  • Asthma
  • Crohn’s Disease
  • Ulcerative Colitis

 

Foracort Inhaler has been known to work well among patients with lung disorders.

Dosage

As directed by your physician

Administration

As directed by your physician

Adverse Reactions/ Side Effects

Cushing’s syndrome, adrenal suppression, growth retardation, decreased bone density, cataract, glaucoma, psychiatric/behavioural effects.

Warnings and Precautions

Patient w/ TB, fungal or viral infections in the airways, CV disease, osteoporosis, peptic ulcer, cataracts, thyroid disease, seizure disorder; existing or family history of severe affective disorder, DM and glaucoma. Not intended for relief of acute bronchospasm. Avoid abrupt withdrawal when switching from systemic to oral or orally inhaled corticosteroid. Hepatic and renal impairment. Childn. Pregnancy and lactation. Monitoring Parameters Monitor BP, serum glucose, growth in paed patients; signs and symptoms of hypercorticism or adrenal suppression.

Contraindications

Oral inhalation: Primary treatment of acute asthmatic attacks or status asthmaticus when intensive measures are required. Rectal: Hepatic cirrhosis w/ signs of portal HTN.

Drug Interactions

Increased systemic exposure w/ potent CYP3A4 inhibitors (e.g. ketoconazole). Decreased systemic exposure w/ CYP3A4 inducers (e.g. carbamazepine).

Overdosage

Symptoms: Decreased motor activity, piloerection, generalised oedema. Management: Immediate gastric lavage or emesis followed by supportive and symptomatic treatment.

Storage

Inhalation: Store between 20-25°C.

Mechanism of Action

–

References

https://www.mims.com/india/drug/info/budesonide/?type=full&mtype=generic#Actions

If you are a healthcare practitioner and want additional material on the brand, disease, or molecule we have a few articles that can be hand-delivered by the company representative to you directly.

MEDIA

NEED FURTHER INFO?